Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker.
AzurRx BioPharma, Inc. agreed to buy out its partner, privately held First Wave Bio, Inc., on 13 September...